Aruvant logo

Aruvant jobs and careers

About Aruvant

Aruvant is focused on developing and commercializing gene therapies for hematological diseases utilizing reduced-intensity conditioning.

Founded
2018
Employees
11 to 50

Leadership

The top of Aruvant's org chart, with how many people report into each leader.

MGPhoto of Matt Gline

Matt Gline

CEO

193 reports

RPPhoto of Richard Pulik

Richard Pulik

Chief Financial Officer

27 reports

JBPhoto of Julia G. Butchko

Julia G. Butchko

Chief Development & Technology Officer, Immunovant

26 reports

EVPhoto of Eric Venker

Eric Venker

President & COO

20 reports

MSPhoto of Mayukh Sukhatme

Mayukh Sukhatme

President & Chief Investment Officer

20 reports

JCPhoto of Jo Chen

Jo Chen

General Counsel

11 reports

AGPhoto of Alex Gasner

Alex Gasner

EVP, Roivant Health

10 reports

DKPhoto of Drew Kramer

Drew Kramer

Chief Information Officer

9 reports

IRPhoto of Ian Rosenblum

Ian Rosenblum

Chief Information Officer

7 reports

Board

IOPhoto of Ilan Oren

Ilan Oren

Board Member, Axovant, Roivant

SCPhoto of Sakshi Chhabra

Sakshi Chhabra

Board Member, Roivant

GMPhoto of George Migausky

George Migausky

Board Member, Immunovant

SSPhoto of Senthil Sundaram

Senthil Sundaram

Board Member, Axovant

KS

Kathleen Sebelius

Advisor

KM

Keith Manchester

Board Member, Roivant